Premium
CD38, BCL‐2, PD‐1, and PD‐1L expression in nodal peripheral T‐cell lymphoma: Possible biomarkers for novel targeted therapies?
Author(s) -
Zaja Francesco,
Tabanelli Valentina,
Agostinelli Claudio,
Calleri Angelica,
Chiappella Annalisa,
Varettoni Marzia,
Zinzani Pier Luigi,
Volpetti Stefano,
Sabattini Elena,
Fanin Renato,
Pileri Stefano A.
Publication year - 2017
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.24571
Subject(s) - romidepsin , medicine , brentuximab vedotin , anaplastic large cell lymphoma , oncology , lymphoma , aggressive lymphoma , follicular lymphoma , rituximab , cd30 , histone deacetylase , biology , biochemistry , gene , histone
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom